Explore UAB
UAB Reporter News and Information for the UAB Community
June 24, 2026 Manage Listing

UAB Urogynecology is partnering with Eli Lilly to evaluate an investigational oral GLP-1 medication, Orforglipron, for weight reduction. Research has shown that weight loss may significantly improve urinary leakage associated with Stress Urinary Incontinence (SUI), which is the involuntary leakage of urine during activities such as laughing, coughing, sneezing, exercising, or lifting heavy objects.

You may qualify if you:

  • Were assigned female at birth
  • Are 18 years of age or older
  • Overweight
  • Experience daily urinary leakage

Qualified participants receive:

  • Study-related care at no cost
  • Possible access to an FDA approved oral GLP-1, Orforglipron
  • Compensation for time and participation

To request more information or check eligibility, contact Elizabeth at 205-801-5830 or email This email address is being protected from spambots. You need JavaScript enabled to view it..

To see if you are eligible, please complete the Eligibility Questionnaire.

Looking for other studies?

ResearchMatch is a multi-institution project that pairs volunteers with researchers seeking study participants.

Back to Top